Vantagerx

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

VantageRx's provides a rapid COVID-19 test and as well as an IT application that assists organizations in the required reporting as mandated by the CARES Act when testing possible COVID positive patients. 

The advantages of our product are below:
 - A less invasive In-Vitro Fingerstick Test
 - Tests for both the IgM and IgG Antibodies 
 - Results measured in only 10 Minutes
 - FDA clearance received on March 16th 
 - Sensitivity and Specificity are both > 95% CI (Confidence Interval - The 
 Higher the Percentage means the Greater the Accuracy)
- Order minimum is only 25 units with the capacity for 1 million + at a cost of $16.50/per test
- Option to include the reporting process required by CARES Act (at an additional $3/per upload)

Sign up for free to view info

Email Format Employee directory